ArticleACS omega2025
Sustainable Synthesis of Multifunctionalized Amoxicillin-Loaded Biopolymer Foams.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The development of biocompatible biopolymer foams loaded with antibiotics is crucial to advancing drug delivery systems in biomedical engineering. These materials offer controlled drug release and specialized functionalities for improved therapeutic outcomes. This study presents the development and characterization of antimicrobial polymeric biofoam materials loaded with the drug amoxicillin (AMX). The sustainable synthesis of these biopolymer foams involves a cost-effective, eco-friendly method that incorporates natural starch within poly(vinyl alcohol) (PVA) through an aldehyde cross-linking/stabilizing process. The highly porous structure of the biofoams enabled effective impregnation of the AMX drug using an innovative process involving ultrasonication and vacuum pressure to maximize efficiency and minimize biomaterial loss. The findings demonstrate the potential of these PVA/starch-based biofoams as versatile drug delivery systems with desirable physicochemical and biological characteristics. Detailed investigations were conducted to evaluate morphological features, chemical properties, swelling behavior, in vitro biodegradability, drug release profiles, cell culture, and antimicrobial activity tests of the prepared biofoam samples. Investigating the effect of controlled loading of AMX under laboratory conditions on its release profile and studying its biodegradation in various environments over time represent a critical aspect of this research. The optimal release profile under physiological conditions and the potent inhibition of bacterial growth against
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.